Thesis (M.Tech.: Homoeopathy)--Durban University of Technology, 2008 / Introduction This dissertation entails a homoeopathic proving of ivory from the male African elephant (Loxodonta africana) 30CH with a subsequent comparison to Lac Loxodonta africana. Objectives The primary objective of this proving was to determine the effects of homoeopathically prepared ivory from the male African elephant (Loxodonta africana) in a 30CH dilution and was achieved by administering the remedy to a group of healthy individuals (provers) who will document all symptoms that arise as a result of taking the remedy. These symptoms will be used to identify the therapeutic indications of homoeopathic ivory. With these specific indications being documented the remedy can then be utilized in the sick individual, that present with similar symptoms, to induce a cure. A further objective of this proving is to report any variation that may exist in the comparison of two remedies, namely Lac Loxodonta africana (milk derived from the African elephant) and the remedy used in this proving, ivory from the male African elephant (Loxodonta africana). Methodology The substance was triturated up until the 3CH and subsequently converted into a liquid potency to be potentised up until the 30CH. Granules were then impregnated with the 30CH liquid potency. Ten impregnated granules were then placed in each individual ii lactose powder sachets. A total of six powders were dispensed to the proving participants. The proving was conducted as a double blind placebo controlled study with a total of twenty-six (26) provers that met the inclusion criteria (Appendix A). The group was made up of both homoeopathic students as well as the general public of varying ages, race and gender. The total group was randomly divided into two groups, twenty (20) of which received the homoeopathic remedy, the remainder (6) received placebo. A full case history of each prover was taken before commencing the proving as well as on completion of the study. Each individual prover kept a journal, starting a week before the proving, which was continued while taking the remedy and ceased when all symptoms had abated. Once all provers had completed the proving, the information received from the provers through the journals from both groups was collated, assessed and analyzed. A comparison was then made between this proving and Lac Loxodonta africana to assess whether any similarities or differences were evident. The comparison was made on symptom similarities and rubric analysis. Results The proving of ivory from the African elephant (Loxodonta africana) revealed a variety of symptoms. A total of 32 systems were affected in the twenty provers who received the remedy. 716 symptoms were recorded, 83 of which were new symptoms. The systems that were predominately affected were the mind, head and extremities. Many symptoms were confirmed to be similar to those identified in the proving of Lac Loxodonta africana, though differences were also acknowledged.

Thesis (M.Tech.: Homoeopathy)--Durban University of Technology, 2008 / Introduction This dissertation entails a homoeopathic proving of ivory from the male African elephant (Loxodonta africana) 30CH with a subsequent comparison to Lac Loxodonta africana. Objectives The primary objective of this proving was to determine the effects of homoeopathically prepared ivory from the male African elephant (Loxodonta africana) in a 30CH dilution and was achieved by administering the remedy to a group of healthy individuals (provers) who will document all symptoms that arise as a result of taking the remedy. These symptoms will be used to identify the therapeutic indications of homoeopathic ivory. With these specific indications being documented the remedy can then be utilized in the sick individual, that present with similar symptoms, to induce a cure. A further objective of this proving is to report any variation that may exist in the comparison of two remedies, namely Lac Loxodonta africana (milk derived from the African elephant) and the remedy used in this proving, ivory from the male African elephant (Loxodonta africana). Methodology The substance was triturated up until the 3CH and subsequently converted into a liquid potency to be potentised up until the 30CH. Granules were then impregnated with the 30CH liquid potency. Ten impregnated granules were then placed in each individual ii lactose powder sachets. A total of six powders were dispensed to the proving participants. The proving was conducted as a double blind placebo controlled study with a total of twenty-six (26) provers that met the inclusion criteria (Appendix A). The group was made up of both homoeopathic students as well as the general public of varying ages, race and gender. The total group was randomly divided into two groups, twenty (20) of which received the homoeopathic remedy, the remainder (6) received placebo. A full case history of each prover was taken before commencing the proving as well as on completion of the study. Each individual prover kept a journal, starting a week before the proving, which was continued while taking the remedy and ceased when all symptoms had abated. Once all provers had completed the proving, the information received from the provers through the journals from both groups was collated, assessed and analyzed. A comparison was then made between this proving and Lac Loxodonta africana to assess whether any similarities or differences were evident. The comparison was made on symptom similarities and rubric analysis. Results The proving of ivory from the African elephant (Loxodonta africana) revealed a variety of symptoms. A total of 32 systems were affected in the twenty provers who received the remedy. 716 symptoms were recorded, 83 of which were new symptoms. The systems that were predominately affected were the mind, head and extremities. Many symptoms were confirmed to be similar to those identified in the proving of Lac Loxodonta africana, though differences were also acknowledged. / M